NCT03769181 2025-09-23A Study of Isatuximab-based Therapy in Participants With LymphomaSanofiPhase 1/2 Terminated58 enrolled 37 charts
NCT04373083 2021-01-15Anti-PD-1 Antibody Treatment With Cemiplimab and Radiotherapy in Early-stage Classical Hodgkin LymphomaRegeneron PharmaceuticalsPhase 2 Withdrawn